"Fees, Pharmaceutical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Amounts charged to the patient or third-party payer for medication. It includes the pharmacist's professional fee and cost of ingredients, containers, etc.
| Descriptor ID |
D005252
|
| MeSH Number(s) |
N03.219.442.551
|
| Concept/Terms |
Fees, Pharmaceutical- Fees, Pharmaceutical
- Fees, Pharmaceutic
- Fee, Pharmaceutic
- Pharmaceutic Fee
- Pharmaceutic Fees
- Pharmacy Fee
- Pharmaceutical Fees
- Fee, Pharmaceutical
- Pharmaceutical Fee
- Fee, Pharmacy
- Fees, Pharmacy
- Pharmacy Fees
|
Below are MeSH descriptors whose meaning is more general than "Fees, Pharmaceutical".
Below are MeSH descriptors whose meaning is more specific than "Fees, Pharmaceutical".
This graph shows the total number of publications written about "Fees, Pharmaceutical" by people in this website by year, and whether "Fees, Pharmaceutical" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 2 | 2 |
| 2003 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fees, Pharmaceutical" by people in Profiles.
-
Cost effectiveness of lopinavir/ritonavir compared with atazanavir in antiretroviral-naive patients: modelling the combined effects of HIV and heart disease. Clin Drug Investig. 2007; 27(1):67-74.
-
Treatment of pulmonary arterial hypertension: a preliminary decision analysis. Chest. 2003 Dec; 124(6):2087-92.
-
Renal transplant patient compliance with free immunosuppressive medications. Transplantation. 2000 Oct 27; 70(8):1240-4.
-
Impact of zidovudine-based triple combination therapy on an AIDS drug assistance program. J Acquir Immune Defic Syndr. 2000 Apr 01; 23(4):302-13.
-
New considerations for Haemophilus influenzae type b vaccination. Clin Pharm. 1992 Apr; 11(4):332-6.
-
Public pressure ends 'bundled' drug program, but how much cost will drop remains unclear. JAMA. 1991 Feb 20; 265(7):837-8.